Don't Expect Tresiba to Have Much Benefit Over Other Longer-Acting Insulins

January 2016

Reps will promote Tresiba (treh-SEE-bah, insulin degludec), a new once-daily ULTRA long-acting insulin.

It lasts about 42 hours...compared to about 24 hours for Lantus or Levemir and a little over 24 hours for Toujeo.

You may hear that Tresiba's longer duration means it doesn't need to be used at the same time every day.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Blood Pressure Consider Lower Systolic BP Goals in SOME Patients
Antibiotics Know When to Bench Quinolones
NSAIDs Consider Topical NSAIDs for Fewer GI Adverse Effects
Naloxone Prescribe Naloxone to Save a Life During Opioid Overdose
Hepatitis C Emphasize Adherence to Help Boost Hep C Cure Rates
Antipsychotics Be Aware that Abilify is Linked to Uncontrollable Gambling and Hypersexuality
Cardiology Don't Switch Most Stent Patients From Clopidogrel to Another Antiplatelet Med
Vaccines Don't Stop Statins in Patients Getting the Flu Vaccine
Asthma Consider Just a Single Dose of Dexamethasone for Asthma Exacerbations
Contraceptives Stop Hormonal Contraceptives by Age 55
Diabetes Don't Expect Tresiba to Have Much Benefit Over Other Longer-Acting Insulins